Peptide CDMO Partner vs Transactional Sourcing: 5 Mekhahlelo

"Peptide CDMO molekane" e bolela'ng ha kamano e kopantsoe ho e-na le transaction?

Phapang ha se hore na barekisi ba thathamisa litšebeletso tse kae. Ke mang ea tšoereng tsebo ka molek'hule ea hau lipakeng tsa mekhahlelo.

Peptide CDMO Partner vs Transactional Sourcing: 5 Mekhahlelo

Litšebeletso Ho fumana peptide ea transaction, morekisi o etsa sehlopha se le seng mme boitlamo bo fela, joalo mohato o mong le o mong o mocha o qala phetiso ea theknoloji hape. Ka nts'etsopele e kopaneng ea peptide, sehlopha se le seng sa tekheniki se lula holim'a molek'hule ho pholletsa le mekhahlelo, e leng sona se etsang hore tswelopele e be teng ho ena le ho tshepisa feela.

Tsoelo-pele ke sehlopha sa maemo a ka netefatsoang, eseng letšoao la likamano. E hloka phepelo ea bekapo e lokiselitsoeng esale pele, papiso ea tlhahlobo e ngata ho isa ho e ngata tlasa boitsebiso bo tšoanang le litekanyetso tsa bohloeki, lintlha tsa mokhoa o senotsoeng le data e tala, ho lateloa ka botlalo ha batch ho tloha ho vial ho khutlela ho lirekoto tsa synthesis, le taolo e ngotsoeng ea phetoho e hlokang tsebiso pele ho phetoho efe kapa efe ea thepa sebakeng sa synthesis, Mokhoa oa QC, lisebelisoa tse so fetoloe, tlhoekiso, ho phuthela kapa ho ngola. Morekisi ea nkang e 'ngoe ea tse joalo e le mohopolo ho fapana le boemo bo netefalitsoeng ha a so rarolle tsoelopele., eng kapa eng eo konteraka e e bitsang kamano. Maemo ao a mahlano a theha lethathamo le tsoelang pele leo u ka le isang tlhahlobong ea hau e latelang ea morekisi.

Key Takeaway: Transactional sourcing e reka sehlopha ebe e felisa boitlamo. Molekane ea kopaneng oa peptide CDMO o boloka sehlopha se le seng le ketane e le 'ngoe ea tsebo molek'huleng ho pholletsa le mohato o mong le o mong o latelang.

Peptide CDMO Partner vs Transactional Sourcing: 5 Mekhahlelo

Papiso e potlakileng: transaction sourcing vs molekane ea kopaneng oa CDMO ea peptide

Phapang eo ho bonolo ho e bona e bapile, kahoo tafole e ka tlase e fana ka lintlha tsa mefuta e 'meli ho pholletsa le mekhahlelo e etsang qeto ea ho reka.

Sehlopha

Ho fumana peptide ea transaction

Molekane oa CDMO ea peptide e kopaneng

Molemo ka ho fetisisa bakeng sa

E hlalositsoe, tatellano e kantle ho sethala ntle le nts'etsopele ea litsela, ha ho na sekhahla, 'me ha ho faele ea taolo e khomaretsoeng

Mananeo a lebisang mosebetsing o nolofaletsang IND, ho phahamisa, kapa kopo ea khoebo

Ke mang ea nang le tsela ea maiketsetso

Mofani; o fumana lengolo la tlhahlobo, eseng tsela

E arolelanoe; tsebo ea litsela e lula le lenaneo ho pholletsa le mekhahlelo

Mokhoa oa ho hlahloba

Mekhoa ea barekisi ka tlung; u fumana liphetho, eseng data e tala

Mekhoa le phetiso ea data e tala ka lenaneo

Mojaro oa phetisetso ea tekhenoloji ho switjha

Phetiso e felletseng: $300,000–$800,000+ le 6-12 likhoeli ho letšolo la pele la cGMP (PeptideStaff, kgutlisitsoe 2026-09-04)

Tlase, hobane sebaka se amohelang se se se ntse se tšoere tsela le mekhoa

Fetola tsebiso

Liphetoho tsa tsela kapa sebaka sa marang-rang li ka fihla ho uena feela joalo ka setifikeiti se secha

Taolo ea phetoho e tsamaisana le tumellano ea boleng bo arolelanoang

Tlhokomelo ea DMF

Arola lintlafatso kapa lintlafatso tsa DMF nako le nako ha u tsamaea

DMF e le 'ngoe e ile ea lula e le teng ho pholletsa le mekhahlelo

Tsela ea ho phahamisa

E fetisetsoa sebakeng se seng le se seng, hangata e netefatsoa hape

E tsoelang pele ho tloha ho milligrams ho ea ho lik'hilograma

Boemo ba litšenyehelo

Tlase ka gram ka tekanyo e nyane

GLP-1 API cGMP e bonts'a litheko tsa litheko $2,500–$5,000/g ho 1–10 kg, oela ho $400–$800/g ho 100+ kg (PeptideStaff, kgutlisitsoe 2026-09-04)

Kahlolo ea rona

E hlolang bakeng sa hang-hang, Reka bongata bo sa faneng

E hlolang hang ha lenaneo le tlameha ho pholoha switjha, ho phahamisa boemo, kapa tlhahlobo

Litlhahiso tse peli ka lipalo. Lipalo-palo tsa phetisetso le tse peli tsa ho fumana chelete li tsamaellana: PeptideStaff ha e senole mokhoa oa ho sebetsa, kahoo li nke e le mekhahlelo ea moralo ho e-na le ho qotsa. 'Me li-CDMO tse' maloa tse kholo joale li behile boitlamo bo fokolang ba sehlopha sa khoebo ea 50- 100 lik'hilograma, e fetolang moruo bakeng sa lenaneo lefe kapa lefe le sa kgoneng ho itlama ka bophahamo boo.

Sethala 1: Mokhoa oa ho kopanya le ho fetola - ke mang ea nang le tsela?

phallo e lehlakoreng le e 'ngoe e bonts'ang tsela ea transaction-to-COA e qetellang ka thomello haufi le tsela e kopaneng moo tsebo ea litsela., mekhoa le batch h

Peptide Synthesis Molekane ea kopaneng o hlola sethaleng sena, mme lebaka ha se bokgoni. Ke tsebo ea tsela eo, eseng sehlopha, ke letlotlo. Morekisi o fana ka linkho le invoice; molekane ea kopantseng o fana ka tsela ea ho kopanya, mabaka a ka morao ho khetho e 'ngoe le e' ngoe ea ho kopanya le ho sireletsa, le tlaleho ea se ileng sa lekoa le ho lahloa.

Meeli ea tšebetso e tlalehiloeng ea SPPS e fapana ho ea ka mohloli, 'me ho se lumellane ho bohlokoa ho feta setšoantšo se le seng. Neuland Labs e beha siling e sebetsang ka thata 30 ho 40 li-amino acid, ha a Tataiso ea sehlopha sa PharmaSource litlaleho 50 ho 70 mesaletsa e ka finyelloang ka k'hemistri e ntlafalitsoeng. Ka bobeli li hlalosa synthesis ea peptide e tiileng tlasa menahano e fapaneng mabapi le resin, ho kopanya li-reagents le mamello ea tlhoekiso, ke ka lebaka leo tsela e lokelang ho ahloloa khahlano le tatelano ea hau ho fapana le nomoro ea sehlooho.

Mokhoa oa ho hloleha ke konkreite. Ketane e fetotsoeng ea masala a 40 e ka kopanya ka mokhoa o amohelehang ka tekanyo e nyane ebe e kopanya nakong ea tlhoekiso., ho putlama ha kotulo sebakeng seo thepa e turang haholo. Setsi sa tsebo sa Bachem e hlokomela hore li-analogue tsa GLP-1 hangata li sebetsa 30 ho 40 li-amino acid kapa ho feta, mme tekanyo eo e tloha ho li-milligrams le ligrama ha ho sibolloa ka lik'hilograma ho nts'etsopele ea bongaka ho ea ho matšolo a khoebo a lik'hilograma tse ngata.. Tsela e so kang ea lekoa khahlanong le tsoelo-pele eo ke tsela eo u tla e ntlafatsa hamorao, hangata tlas'a khatello ea nako.

Counterion exchange belongs in the same conversation. Trifluoroacetate is the default counterion left behind by standard reverse-phase purification, and swapping it for acetate or chloride changes the salt form, the residual TFA profile and the impurity picture your later analytical work will report. If the supplier controls that decision without telling you, your Stage 2 results will describe a material you did not intend to specify.

Kahlolo: the integrated partner wins on custom peptide synthesis and modification, because the route, its counterion strategy and the reasoning behind both transfer with the relationship. A transactional supplier can match the batch and still leave you with nothing to build on.

Sethala 2: Tlhahlobo ea tlhahlobo - mekhoa ea mang, eo data e tala?

Molekane ea kopantseng o tla hapa mohato ona hobane mokhoa oa ho ba mong'a thepa le phihlello ea data e tala ke tsona tse etsang hore phetoho e be teng hamorao.. Mofani oa thekiso ea thepa o romela setifikeiti sa tlhahlobo; molekane ea kopaneng a ka fana ka lintlha tsa mokhoa o senotsoeng le data e tala ka morao ho setifikeiti seo: chromatogram ea 'nete, kholomo le mothako o sebedisoang, le netefatso ea orthogonal joalo ka tlhahlobo ea amino acid. Phapang eo ke ea bohlokoa haholo ha ho le thata ho boloka bohloeki. Litlhaloso tsa Peptide API hangata li koahela litšila tsa motho ka mong ho ≤0.1%, le ho fihla >95% ho hloeka ka tekanyo ea kilogram hangata ho hloka mehato e mengata ea ho itokisa HPLC hammoho le lyophilisation e laoloang, ke ka hona ts'ebetso e sebetsang ho 100 mg e ka hloleha ho 10 kg. Bakeng sa thepa ea boemo ba meriana, lebella ≥95% bohloeki 'me u kope litlaleho tsa batch tse bontšang >98% bohloeki mmoho le boemo bo felletseng ba ditshila. Netefatsa hore mokhoa o hlophisitsoeng o akaretsa HPLC kapa UPLC, LC-MS, MALDI-TOF, tlhahlobo ea amino acid, Tlhahlobo ea endotoxin ea LAL ka USP <85>, le sterility ho latela USP <71>, le hore mekhoa e netefalitsoe ho ICH Q2(R2) litebello. Haeba thepa e le ea boemo ba lipatlisiso 'me ha ho na ho faela ho itšetlehileng ka eona, COA ea transaction e lekane.

Sethala 3: Ntlafatso ea ts'ebetso le ho phahamisa - moo mohlala oa transaction o robehang

Ts'ebetso ea transaction e emisa ho sebetsa mona hobane sekala se fetola ts'ebetso, eseng feela boholo ba batch. Tsela e fanang ka gram ka bohloeki bo phahameng e ka hloleha ka tekanyo ea kilogram hang ha boima ba chromatography, meqolo ea solvent le profiles tsa litšila lia fetoha. Tsoelo-pele ea mg-to-kilogram tlhahisong ea li-peptide e tloha ho bongata ba phumano ea milligram le gram ka phepelo ea kliniki ea kilogram ho ea ho lihlopha tsa khoebo tsa lik'hilograma tse ngata., 'me mohato o mong le o mong ke mokhoa o mocha oa ho tšoaneleha ho e-na le phetolelo e kholoanyane ea ea ho qetela.

Thero ea bokhoni e na le leraba la bobeli. Joalo ka ha DataM Intelligence e bolela tlalehong ea eona ea 'maraka ea peptide CDMO, Phatlalatso ea molumo oa reactor ha e fetohe hanghang bokhoni ba bareki, hobane thepa e ncha e tlameha ho hlakola kaho, ho laela thepa, ts'ebetso ea thuto le netefatso pele. Bokhoni bo fokolang ba maemo a khoebo ke thibelo e nang le tšusumetso e phahameng 'marakeng.

Tataiso kemiso ea nako ea ho etsa peptide mohato ka mohato ho tsoa ho CDMO Hub beha kliniki GMP mosebetsi ho 3 ho 6 likhoeli le khoebo seka-up ka 12 ho 24 likhoeli kapa ho feta, ka netefatso le tlatsetso ea faele 6 ho 12 likhoeli. Tšoara tsena e le mekhahlelo ea moralo, eseng boitlamo: motataisi ha a qotse mokhoa, 'me linako tsa sebele li itšetlehile ka ho rarahana ha litsela, leano la taolo ea ho se hloeke le mojaro oa litšoaneleho oa sebaka sa ho amohela.

Sethala 4: Fetola puso le litšenyehelo tsa sebele tsa ho fetola lenaneo la bohareng

Molekane ea kopaneng oa peptide CDMO o hapa litšenyehelo tsa ho chencha, 'me lekhalo le pharaletse ho lekana ho fetola qeto ea ho reka. Published estimates put the cost of switching peptide CDMO partners mid-program at $300,000 ho $800,000 or more, ka Li-Peptide tsa Synthetic 6 ho 12 months to the first cGMP campaign and a further 10 ho 20 percent added for dual sourcing. Those figures are directional and the methodology behind them is not disclosed, so treat them as a planning range rather than a quote.

The regulatory layer compounds the money. A transactional model means separate DMF updates or amendments each time a supplier, site or method changes, and analytical methods usually need revalidation on top of that. An integrated relationship keeps one DMF current instead.

Two mechanisms reduce that burden when they are planned in advance. ICH Q12’s change-management protocol, e hatisitsoeng 19 Pulungoana 2019, lets a sponsor agree acceptance criteria prospectively, kahoo protocol e phethiloeng e na le mojaro o fokolang oa taolo ho feta tlhahiso e felletseng ea tumello ea pele. Moralo oa papiso-protocol oa FDA o sebetsa ka mokhoa o ts'oanang: liteko, lithuto le mekhoa ea ho amohela li ngotsoe pele ho phetoho, mme moetsi o netefatsa litlamorao ho boitsebahatso, matla, boleng, bohloeki le matla pele ho kabo.

Hlokomela ntlha e qalang. Ho fetola sebaka sa thepa ea lithethefatsi ho hlahisa tsebiso ea taolo neng kapa neng ha setsi se fapana le kopo e amohetsoeng, libaka tse mahareng li kenyelelitsoe. Ke ka lebaka leo ho ngotsoeng ho fetola puso pele phetoho leha e le efe ea thepa e le ea konteraka: tsebiso pele ho phetoho leha e le efe sebakeng sa synthesis, Mokhoa oa QC, lisebelisoa tse so fetoloe, tlhoekiso, ho phuthela kapa ho ngola. Ts'ebetso ea rekoto ea sehlopha ho pholletsa le liphetoho tseo e lokela ho kopana le litebello tsa botšepehi ba data tsa MHRA ALCOA, kahoo mokhoa oa ho hlahloba o pholoha phetoho le haeba molekane a sa etse joalo.

Sethala 5: Sephutheloana sa phetisetso se ngotsoeng se lokela ho ba le eng

a four-block transfer-package checklist covering process, mekhoa ea ho hlahloba, litlhaloso, and materials and batch history, with the common omissio

A written peptide tech-transfer package should contain four blocks: tshebetso (tsela ya maiketsetso, maemo, li-reagents, lintlha tse bohlokoa); mekhoa ea ho hlahloba (HPLC, MOF, release methods, litekanyetso tsa litšupiso); litlhaloso (bohloeki, meeli ea litšila, boitsebiso, content criteria); and materials and history (mehloli ea lintho tse tala, prior batch records, known risks) (Global Biotech Laboratories, kgutlisitsoe 2026-09-02). Incomplete packages typically miss critical process parameters, undocumented known issues, or unstated specifications.

Bakeng sa Keletso: Start with analytical method transfer. Methods must be reproduced and verified before they gate any batch, so sequencing it first removes the most common cause of stalled technical dialogue.

The documented sequence runs kickoff and gap assessment, documentation transfer, phetiso ya mokgwa wa tshekatsheko, a non-GMP demonstration batch, then confirmation and scale (Global Biotech Laboratories, kgutlisitsoe 2026-09-02). That source is a CDMO that sells transfer services, so treat its timeline, "taba ea libeke ho isa ho likhoeli tse 'maloa" bakeng sa phetisetso e lokiselitsoeng hantle e nang le litokomane tse felletseng le tataiso e inehetseng ea botekgeniki, joalo ka morekisi ea ratwang ho ena le ho se nke lehlakore.

Lintho tse lokelang ho ba teng khahlano le lifolakha tse khubelu: mokhoa oa ho fumana molekane ofe kapa ofe oa CDMO oa peptide

Morekisi ea sa khoneng ho araba potso ea mokhoa a ke ke a phela ha a fetoha. Fumana molekane ofe kapa ofe oa CDMO oa peptide mananeng a mabeli a ka tlase, le ho ba arola: lintho tseo u tlamehang ho ba le tsona ke tseo u li hlokang ha u ngola pele u saena, lifolakha tse khubelu ke seo u tsamaeang ho sona.

Lintho tseo u lokelang ho ba le tsona

  • Lintlha tse hlahisitsoeng mabapi le mokhoa le data e tala, eseng kakaretso

  • Temana e ngotsoeng ea phetoho-tsebiso

  • Batch traceability ho tloha vial ho khutlela ho synthesis le lirekoto tsa QC

  • Moetapele ea bitsoang tekheniki, ha se inbox e arolelanoang

  • Mokhoa o boletsoeng oa ho phahamisa maemo o nang le lintlha tsa bohlokoa

Lifolakha tse khubelu

  • COA-feela likarabo lipotsong tsa mekhoa

  • Ha ho na mokhoa o ngotsoeng oa taolo ea phetoho

  • Sephutheloana sa phetisetso ha se na lintlha tsa bohlokoa tsa ts'ebetso

  • Litlaleho tsa bokhoni tse hahelletsoeng holim'a molumo o phatlalalitsoeng oa reactor, e sa fetoheng hanghang bokgoni ba bareki

  • Ho itšetleha ka sebaka se le seng ho se na bekapo e nang le tsebo esale pele

Tšoara lethathamo la lintho tseo u lokelang ho ba le tsona e le lethathamo le tsoelang pele leo u ka le isang tlhahlobong ea hau e latelang ea barekisi.

Ke mang ea lokelang ho khetha mofuta ofe

Haeba lenaneo la hau ke boemo ba lipatlisiso kapa boemo ba tlhahlobo, ntle le ho itšetleha ka ho kenya le molek'hule u ka e lahla kotara e tlang, Ho fumana peptide ea transaction ke mohala o nepahetseng. U fumana lethathamo kapa qotso e ikhethileng, setifikeiti sa tlhahlobo, 'me ha ho na likamano tse feteletseng. Ha ho na letho la mofuta o kopaneng oa nts'etsopele ea peptide le fumanang moputso oa lona nakong eo.

Hang ha lenaneo le leba mosebetsing oa ho nolofalletsa IND, calculus ea phethoha. Mokhoa oa phetisetso le ts'ebetso ea ts'ebetso ea litšila: mohato o mong le o mong o mocha o qala phetiso ea theknoloji hape, 'me nalane ea tlhahlobo eo u e hahileng ho e fetileng e tlameha ho hahuoa bocha ke mang kapa mang ea nkang mohato o latelang. Molekane ea seng a tšoere tsela, mekhoa le data e tala e tlosa hore restart.

Mananeo a sebetsang ho mofani oa thepa ea sebetsang ea bontšang matšoao a ho hlōleha a hloka tsela ea boraro: molekane ea kopantseng mmoho le bekapo e lokiselitsoeng esale pele, ka litšenyehelo tsa ho chencha balekane ba CDMO ea peptide bohareng ba tekanyetso pele u e hloka, eseng kamora.

Nyeoe e le 'ngoe e tšoaneloa ke botšepehi. Haeba molek'hule ke peptide e khuts'oane e sa fetoloang tseleng e holileng, tefiso ea ho tsoela pele e reka hanyane. Tsela ke ea thepa, mekhoa e tloaelehileng, 'me mofani oa thepa a ka fana ka sephutheloana se feletseng ntle le tahlehelo e ngata.

Moo chelete e tsoelang pele e lefang ke mekhahlelo eohle e arolelanang data. Molekane ea ts'ehetsang nts'etsopele ea litsela, mokhoa oa ho hlahloba botho le ho phahamisa tlas'a tsamaiso e le 'ngoe ea boleng bo ka sebelisoa ho jara boemo bo tšoanang ba litšila ho tloha ho milligram ho ea ho tlhahiso ea kilogram., e thusang ha molaoli a botsa hore na ho se hloeke ho itseng ho ne ho laoloa joang mothating ka mong. Ke ona mochine, eseng lepetjo: li-handoffs tse fokolang, netefatso e fokolang, dataset e le 'ngoe e ka latelloang.

Lipotso tse botsoang khafetsa

A na nka chencha balekane ba peptide CDMO bohareng ba lenaneo?

Ee, empa e nke joalo ka morero, eseng taelo ea ho reka. Hoa khoneha ho fetola lenaneo la bohareng; tšitiso ke litšenyehelo tsa ho fetola balekane ba CDMO ba peptide bohareng ba lenaneo, e lebisang nqa e batlang e lekana $300,000 ho $800,000 le likhoeli tse ts'eletseng ho isa ho tse leshome le metso e 'meli hang ho nchafatsoa ha mokhoa le liphetoho tse arohaneng tsa Drug Master File li baloa. Tatelano e bohlokoa ho feta lebelo: fetisetsa le ho netefatsa mekhoa ea ho hlahloba pele, ebe u tšoaneleha tsela e ncha, 'me feela ka nako eo etsa batch. Ho qala ka sehlopha ho khelosa tatellano mme hangata e qobella ho pheta-pheta.

A na nka sebelisa mofani oa thepa le molekane ea kopaneng hammoho?

Ee, le mananeo a mangata a etsa joalo. Karohano e ntseng e le teng ke ho fumana thepa bakeng sa ho etsa lipatlisiso tsa maemo a holimo kapa tse sa ngolisoeng, le molekane ea kopaneng ea nang le tsela le mekhoa e amanang le ho faela. Maemo a mabeli a etsa hore e sebetse. Ea pele, tekanyetso ea tefiso ea dual-sourcing, kaha ho tsamaisa litsela tse peli tsa phepelo ho bitsa chelete e ngata ho feta e le 'ngoe. Ea bobeli, beha taolo ea phetoho e ngotsoeng pele ho phetoho efe kapa efe ea lintho tse bonahalang, kahoo mofani oa thepa ka lehlakoreng la skrine a ke ke a fetola ka khutso hore na ho faela ho itšetlehile ka eng.

Ke mohlala ofe o fanang ka taolo e ntle ea tlhahlobo?

Mohlala o kopantsoeng, hobane phihlello ea data e tala le beng ba mekhoa ke tsona tse ka sehloohong, eseng lenane la lisebelisoa. Taolo ea litšila ke moo seo se bontšang: ho lokolla peptide ka holimo 95% ka tekanyo ea kilogram hangata e hloka HPLC e itokisang ea mehato e mengata, le litebello tsa pharmacopoeial bakeng sa lintho tse amanang li lutse ho kapa ka tlase 0.1% bakeng sa ditshila tsa motho ka mong (USP, kgutlisitsoe 2026-09-15). Kopa molekane ofe kapa ofe bakeng sa lirekoto tsa sehlopha >98% bohloeki mmoho le boemo bo felletseng ba ditshila, le bakeng sa li-chromatogram tse ka tlase ho e-na le tafole ea kakaretso.

Ho phatlalatsoa bokhoni ba tlhahiso ea peptide bo lekanang le bo fumanehang?

Che. Bophahamo ba actor e phatlalalitsoeng ha e fetohe hanghang bokhoni ba bareki, hobane kaho, ho laela, litsebo tsa ts'ebetso le netefatso kaofela li tlameha ho phetheloa pele. Bala liphatlalatso tsa hajoale tsa katoloso joalo ka lipeipi, ho se fumanehe: Polante ea li-peptide tse limilione tse 500 ea CordenPharma haufi le Basel e shebane le ts'ebetso ea khoebo ho H1 2028, Setsi sa Sisslerfeld sa Bachem se lebelletsoe ho kena 2030, 'me katoloso ea WuXi AppTec's Taixing e tlisitse molumo o felletseng oa li-reactor tsa SPPS ka holimo 100,000 L (Data Intelligence, 2026). Rera khahlanong le mela e tšoanelehang, eseng lithara tsa sehlooho. Tlhahiso ea Peptide

Na ho fumana peptide ea transaction e ntse e lokela ho sebelisoa?

Ee, ka hare ho moeli. Transactional peptide sourcing ke mohlala o nepahetseng oa lisebelisoa tsa sehlopha sa lipatlisiso le tlhahlobo ea pele, moo ho se nang faele ho ipapisitseng le tsela kapa mekhoa, le moo lebelo le theko ea unit li busang teng. E emisa ho lekana hang ha lenaneo le hloka mosebetsi o nolofalletsang IND, ho hlahisa ditshila kgahlanong le sebono se hlalositsweng, kapa tsela e netefalitsoeng ea ho eketsa sekhahla. Letšoao la ho shebella ha se boholo ba batch empa ke ho itšetleha: nako eo tlhahiso ya taolo e itshetlehileng hodima tsela kapa mokgoa, mohlala oa transaction ha o sa koahela kotsi.

Mehato e latelang

Khetha mokhoa oa ho fumana peptide ea transaction ha o hloka molek'hule e hlalositsoeng ka mokhoa o hlalositsoeng mme ha ho letho le tlase ho latela tsebo ea morekisi.. Khetha molekane oa CDMO ea kopaneng ea peptide ha lenaneo le tloha ho lekola ho leba IND-e nolofalletsang mosebetsi le ho tsoela pele ha tsela., mekhoa le data e ba ntho eo u hlileng u e rekang.

Haeba u ntse u hlahloba bocha lenaneo la bohareng ba molekane, tsela e potlakileng ea ho leka kamano ke ho kopa sephutheloana sa phetisetso se ngotsoeng se hlalositsoeng Stage 5 mme o bone hore na e ngata hakae. Molekane ea ka e hlahisang kapele o se a ntse a sebetsa ka tsela eo u e hlokang. About

Bua le sehlopha sa rona sa tekheniki haeba u batla ho feta sethaleng sa lenaneo la hau le mekhoa e bohlokoa haholo ho eona.

Tsebiso: MOL Changes e na le thahasello ea khoebo ho litekanyetso tsa boleng ba peptide mme e sebetsa le batšehetsi ho latela mekhoa e hlalositsoeng sehloohong sena.

Bingyan Gao

Bingyan Gao

Setsebi sa Boleng le Tlhahlobo Tsebo ea Konokono: Karohano le ho tsebahatsa litšila tsa mesaletsa, HPLC/MS mokhoa oa ntlafatso, tlhahlobo ea bohloeki ba chiral, le ho lumellana le lipharmacopoeia tsa machaba.

Profile: Bingyan Gao ke "molebeli oa heke oa ho qetela" oa bohloeki le boleng ba peptide. O hloahloa tšebelisong ea lisebelisoa tse fapaneng tsa tlhahlobo ea maemo a holimo mme o ipabola ho nts'etsopeleng mekhoa e ikhethileng ea karohano ea chromatographic bakeng sa li-peptide tse fetotsoeng tse rarahaneng haholo.. O thehile mokhoa o matla oa ho hlahisa litšila tse sa hloekang o sa tiiseng feela bohloeki ba sehlahisoa sa 99% kapa e phahameng empa hape e tsebahatsa ka nepo le ho felisa litšila tse ka bakang immunogenicity. Ka kutloisiso e tebileng ea litlhoko tsa taolo tsa FDA le EMA bakeng sa lithethefatsi tsa peptide, o etsa bonnete ba hore sehlopha se seng le se seng se lokolotsoeng setsing se tsamaea le Setifikeiti sa Tlhahlobo se felletseng le se nang le matla. (COA).

'Nete e hlahlobiloe & Litaelo tsa Bahlophisi
E hlahlojoa ke: Litsebi tsa Litaba
Arolelana sehlooho sena
Lehae Batla Whatsapp Litšebeletso Sehlahisoa